164 related articles for article (PubMed ID: 9874677)
1. Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.
Eriksson A; Eriksson B; Holm SE; Norgren M
Clin Diagn Lab Immunol; 1999 Jan; 6(1):133-6. PubMed ID: 9874677
[TBL] [Abstract][Full Text] [Related]
2. Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF).
Eriksson A; Holm SE; Norgren M
Microb Pathog; 1998 Nov; 25(5):279-90. PubMed ID: 9878456
[TBL] [Abstract][Full Text] [Related]
3. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
4. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
Eriksson BK; Andersson J; Holm SE; Norgren M
J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
[TBL] [Abstract][Full Text] [Related]
5. Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF).
Gerlach D; Schmidt KH; Fleischer B
FEMS Immunol Med Microbiol; 2001 Apr; 30(3):209-16. PubMed ID: 11335140
[TBL] [Abstract][Full Text] [Related]
6. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome.
Sriskandan S; Moyes D; Cohen J
Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404
[No Abstract] [Full Text] [Related]
8. Staphylococcal and streptococcal superantigen exotoxins.
Spaulding AR; Salgado-Pabón W; Kohler PL; Horswill AR; Leung DY; Schlievert PM
Clin Microbiol Rev; 2013 Jul; 26(3):422-47. PubMed ID: 23824366
[TBL] [Abstract][Full Text] [Related]
9. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
Norrby-Teglund A; Low DE; McGeer A; Kotb M
Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
[No Abstract] [Full Text] [Related]
10. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
11. Cytolysins augment superantigen penetration of stratified mucosa.
Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for group A Streptococcal anti-DNase B in human sera, using recombinant proteins - Comparison to the DNA methyl green micromethod.
Das S; Dileepan T; Johnson DR; Kaplan EL; Patrick Cleary P
J Immunol Methods; 2017 Dec; 451():111-117. PubMed ID: 28939394
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
Sriskandan S; Faulkner L; Hopkins P
Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
[TBL] [Abstract][Full Text] [Related]
14. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.
Proft T; Arcus VL; Handley V; Baker EN; Fraser JD
J Immunol; 2001 Jun; 166(11):6711-9. PubMed ID: 11359827
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
[TBL] [Abstract][Full Text] [Related]
16. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.
Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM
Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
Basma H; Norrby-Teglund A; Guedez Y; McGeer A; Low DE; El-Ahmedy O; Schwartz B; Kotb M
Infect Immun; 1999 Apr; 67(4):1871-7. PubMed ID: 10085030
[TBL] [Abstract][Full Text] [Related]
18. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
[TBL] [Abstract][Full Text] [Related]
19. Superantigens of group A streptococci (Streptococcus pyogenes). Distribution, induction of antibodies, and binding to human cell types.
Wagner B; Gerlach D; Ozegowski JH; Wagner M
Adv Exp Med Biol; 1997; 418():555-7. PubMed ID: 9331712
[No Abstract] [Full Text] [Related]
20. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice.
Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF
Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
